In a recent study from this hospital (Stevens, Abbey, and Shulman, 1963) , a clinical analysis of patients with positive L.E.-cell tests was presented; after SLE, which was the most common diagnosis, rheumatoid arthritis proved to be second in frequency. The finding of L.E.-cells in patients with rheumatoid arthritis did not correlate well with systemic complications. However, the design of the study was such that too few patients with rheumatoid arthritis appeared in the randomly-sampled control group with negative L.E.-cell tests to permit an adequate comparison with those who had L.E.-cells.
The present study was designed, therefore, to determine in a controlled manner the clinical implications of a positive L.E.-cell test in patients with rheumatoid arthritis. The Tests.- All control patients were selected from the index of discharge diagnoses of hospital in-patients. The index code for "rheumatoid arthritis" included not only patients with rheumatoid arthritis fulfilling our criteria but also patients in whom rheumatoid arthritis was included in the differential diagnosis. These latter patients, as well as those with variant forms of rheumatoid disease and juvenile rheumatoid arthritis, were excluded.
An attempt was made to obtain two control patients with negative L.E.-cell tests for each L.E.-cell positive patient matched by year; the desired number of patients could not be obtained, but after review of all indexed cases in 1957, only three less than the number required in this year were found, i.e. 41 instead of 44.
Group 3. 22 Patients with No L.E.-cell Test.-Tbis group was included to evaluate a possible selection bias existing in those patients who had an L.E.-cell test performed. Patients were obtained from the same indexed hospital source as those in Group 2, and again, an attempt was made to obtain twice as many patients, matched on a yearly basis, as in Group 1. This was not possible, however, because it was increasingly difficult in 1956 and thereafter to obtain patients who had not had an L.E.-cell test performed.
Clinical Analysis
The hospital record on each of the 85 patients was summarized in detail and the data obtained at the time of the L.E.-cell test was analysed. In those patients in whom no test was performed (Group 3), the time of admission in the year selected for study was chosen arbitrarily.
Since Group 1 (L.E.-cell positive patients) was composed of out-patients as well as in-patients, these two sub-groups were analysed separately; any differences are presented.
The L.E.-cell tests were performed in the Special Haematology Laboratory of this hospital according to the method of Zinkham and Conley (1956) which was institutcd as routine procedure in 1955. All other laboratory data were obtained from the general hospital laboratories. Tests for rheumatoid factor were not performed routinely during this period; and insufficient data were thus available for including such results in this analysis.
Statements of statistical significance are made only on the basis of the x2 analysis, using Yates' correction or, when mean values were compared, the "t" test.
Results
Age and Sex.-The majority of patients in each group proved to be women over the age of 40 years (Table I) .
Women comprised three-quarters of those with L.E.-cells and approximately two-thirds of the control group. There were, therefore, no significant differences between the groups with respect to age or sex. 
ANNALS OF THE RHEUMATIC DISEASES
However, while in-patients with L.E.-cells had disease averaging 18-6 yrs in duration, out-patients with L.E.-cells had a mean duration of disease of only 5-2 yrs. This difference is highly significant (P <0 01), as is the difference between the in-patients with L.E.-cells anid the in-patient controls (P <0 02).
Clinical Features.-Systemic involvement was infrequent in all three groups and was no more frequent among patients with L.E.-cells than controls (Table IV) .
Except for one patient with pleurisy and another with non-bacterial pneumonitis, clinical manifestations commonly associated with SLE were lacking in the L.E.-cell positive group. However, seven control patients had unexplained low-grade fever and two others had a macular erythematous skin rash. One patient had psoriasis. In none of the 85 patients was there a typical butterfly rash or evidence of renal disease. The only two patients with cardiac disease were controls with rheumatic mitral insufficiency.
Reticulo-endothelial involvement was the most prominent finding, with splenomegaly in five patients and generalized lymphadenopathy in six. Two of those with splenomegaly had Felty's syndrome.
Finally, such "rheumatoid-like" features as leg ulcers and peripheral neuritis were not found in any patient.
Laboratory Investigations (Table V, (Rothfield and Pace, 1962) . Therefore, the character of joint involvement in patients with L.E.-cells was indistinguishable from that found in controls.
Moreover, subcutaneous nodules, the hallmark of rheumatoid disease, occurred no more frequently among those patients with L.E.-cells than in controls. This data would be in agreement with the observations of Kievits and others (1956) , but differs from the correlation of nodules with positive L.E.-cell tests reported by other workers (Friedman and others, 1957; Willkens and Decker, 1963) . Furthermore, when patients with subcutaneous nodules were compared with patients without nodules, irrespective of L.E.-cell testing, no significant differences were found. As noted by Sharp, Calkins, Cohen, Schubart, and Calabro (1964) Of interest in this regard is the more recent report of fourteen patients with severe deforming rheumatoid arthritis (Willkens and Decker, 1963) , in which case selection was based upon the presence of antinuclear factor. L.E.-cells were demonstrated in eight individuals. Proteinuria was noted in half the group, five of the seven patients with proteinuria being among those with L.E.-cells. The clinical picture was not that of glomerulonephritis in any instance; and in two patients with proteinuria and L.E.-cells who came to autopsy no evidence of membranous changes was found. Both patients had nephrosclerosis and, in one, acute arteritis and pyelonephritis were found as well. Pathological lesions most compatible with the diagnosis of SLE were not present in any organ. The lack of renal disease in our patients would, therefore, be in agreement with the observations of most investigators and with the pathological data of Pollak, Pirani, Steck, and Kark (1962) .
In contrast to these observations and the results of the present investigation is the report by Ross and Clardy (1956) of renal disease occurring in sixteen of eighteen patients with rheumatoid arthritis and L.E.-cells. Subsequent follow-up data on this group would be of the utmost importance since, at the time of evaluation, these patients were at an early stage of disease (Stages I and II) and for the most part lacked the destructive joint changes so characteristic of our patients (Stages III and IV). The difficulty in distinguishing early rheumatoid arthritis from SLE manifested predominantly by articular involvement is a major clinical problem which may be reflected in these authors' observations.
The observations presented here would fail to support the concept that the L.E.-cell phenomenon in rheumatoid arthritis implies "lupus-like" disease. Of interest are the two features which were significantly different in patients with rheumatoid arthritis and L.E.-cells compared with controls.
(1) The average white blood cell count in patients with the L.E.-cell phenomenon was lower than in L.E.-CELLS IN RHEUMATOID ARTHRITIS controls and, furthermore, there was also an increased frequency of leucopenia. Although leucopenia occurred more frequently among those with L.E.-cells, it was no more severe in this group than in controls. In none of the three groups could the occurrence of white cell depression be related to current or past therapy. While leucopenia is a frequent feature of SLE, previous studies have paid relatively little attention to this finding in rheumatoid arthritis except when it has occurred in a setting of Felty's syndrome. However, in the selected series of patients with advanced rheumatoid arthritis and antinuclear factor described by Willkens and Decker (1963) , a white blood cell count of less than 5,000 cells/mm.3 was a prominent finding in half the cases, five of whom were among the eight patients with L.E.-cells.
(2) The serum globulin level was higher in those patients with L.E.-cells than in the controls. Nevertheless, the frequency of marked hyperglobulinaemia was the same for these patients and control patients. This increase in serum globulin could not be explained by the greater proportion of Negroes among those with L.E.-cells. In fact, when mean serum globulin levels were determiined from Negroes and whites, the values were surprisingly similar.
With data such as these, one may certainly question the basis for separating patients with rheumatoid arthritis and L.E.-cells from those with negative tests on other than theoretical grounds. Certainly, except for the trend toward leucopenia and hyperglobulinaemia, "lupus-like" features are noticeably absent.
Even as regards the L.E.-cell testper se, differences exist between patients with rheumatoid arthritis and those with SLE. As shown previously (Zimmer and Hargraves, 1952; Monto and others, 1961; Stevens and others, 1963) Leucopenia was more frequent, and the mean white blood cell count was lower in the patients with L.E.-cells. Also, the mean serum globulin level was higher in this group. These were the only statistically significant differences observed and were of small magnitude.
It would appear from these data that there is little justification on clinical grounds for considering rheumatoid arthritis with L.E.-cells to be either an entity distinct from rheumatoid arthritis, or a variant of systemic lupus erythematosus.
Importance clinique du phdnomfne LE dans I'arthrite rhumatismale R#SUME On presente des analyses cliniques de groupes suivants de malades atteints d'arthrite rhumatismale:
(1) 22 malades avec cellules LE; (2) 41 malades au test pour cellules LE n6gatif;
(3) 22 malades chez qui on n'a pas procede au test. Les malades atteints d'arthrite rhumatismale au test pour cellules LE positif se distinguaient peu de ceux dans les deux groupes temoins en ce qui conceme l'inflammation articulaire, la duree de l'arthrite et la pr6sence des nodules souscutanes. Toute atteinte g6n6ralis6e etait fort rare dans tous les groupes des malades et ne survenait pas plus souvent chez ceux qui avaient des cellules LE que chez les autres.
La leucopenie etait plus frequente et la valeur leucocytaire moyenne plus basse chez les malades qui pr6sentaient le phenomene LE. De meme, le taux serique de la globuline etait plus elev6 dans ce groupe. C'etaient les seules differences statistiquement appreciables que l'on avait observe et leur magnitude etait faible.
Ces faits semblent indiquer qu'on a peu de raisons cliniques pour considerer l'arthrite rhumatismale avec des cellules LE comme une entite distincte de l'arthrite rhumatismale ou comme une variante du lupus erythemateux dissemin&.
Significado clinico del fen6meno LE en la artritis reumatoide SUMARIO Se presentan analisis clinicos de siguientes grupos de enfermos con artritis reumatoide:
(1) 22 enfermos con celulas LE; (2) 41 enfermos con el fen6meno LE negativo; (3) 22 enfermos en quienes no se hizo el test. Los enfermos con artritis reumatoide y con celulas LE se distinguieron poco de los en los grupos testigos respecto a la inflamaci6n articular, la duraci6n de la artritis o la presencia de nodulos subcutaneos. Implicaci6n sistemica de qualquier suerte en todos los grupos de enfermos fue rara y no ocurria con mAs frecuencia en los con celulas LE que en los demAs.
La leucopenia fue mAs frecuente y el valor leucocitario medio mas bajo en los enfermos que presentaron el fen6meno LE. Asimismo, el valor serico de la globulina fue mAs alto en este grupo. Estas fueron las uinicas diferencias estadisticamente apreciables observadas y su magnitud fu6 poca.
Estos hechos parecen indicar de que hay pocas razones clinicas para considerar la artritis reumatoide con c6lulas LE como una entidad distinta de la artritis reumatoide o como una variante del lupus eritematoso diseminado.
